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Estimating the Prevalence of Drug Use
Using Mark-Recapture Methods
Gordon Hay and Clive Richardson
Abstract. Sparked by the need to inform the response to the spread of
HIV/AIDS in drug-injecting populations in the 1980s and the desire to base
local, national and international responses to tackling drug use in the 1990s
on solid epidemiological data, the mark-recapture method has increasingly
been used to estimate the prevalence of drug use. Richard Cormack provided
support and advice to some of the first United Kingdom and European studies
to estimate drug use prevalence in this way. The approach he outlined, using
macros that he developed, has led to the mark-recapture method being used
to systematically assess the use of drugs such as heroin or other opioids in
the United Kingdom and across Europe. We review the development of the
method when applied to estimating the size of drug-using populations, in-
cluding the use of Bayesian methods. We discuss its limitations and various
criticisms that have been voiced.
Key words and phrases: Bayesian methods, drugs, heroin use, mark-
recapture, prevalence.
1. INTRODUCTION
1.1 Background
In this paper we describe how the mark-recapture
method has been used to estimate the prevalence of
problem drug use. We begin by examining what is
meant by “problem drug use” and go on to provide a
brief review of the literature on mark-recapture estima-
tion of problem drug use, noting a “standard approach”
that was used in many early studies, including a series
of studies within the United Kingdom. We examine the
key assumptions associated with the mark-recapture
method, particularly how concepts within the ecolog-
ical application of the method relate to a covert human
population. Developing on from the key assumptions,
we review some articles that critically assess whether
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the assumptions are met. We then go on to examine
the use of Bayesian methods within mark-recapture
estimation of drug use and also describe the use of
open-population models in estimating drug-using pop-
ulations.
The mark-recapture methodology provides a sample-
based solution to the problem of estimating the size of
a population when a census is infeasible, likely to be
unreliable or, by the nature of the population, impos-
sible to carry out. The obstacles to counting, which
almost always arise in relation to animal populations,
also often appear when human populations are the
target. Thus, the famous Petersen–Lincoln estimator
was eventually reinvented in the modern demographic
literature in a 1949 paper which bears—like many
other innovations—the name of W. E. Deming (Sekar
and Deming, 1949), although much earlier applica-
tions have been traced within Buckland, Goudie and
Borchers (2000). Sekar and Deming faced the prob-
lem of estimating the total number of births and deaths
in a district where vital registration was incomplete.
Their solution was to use a door-to-door survey to cor-
rect the registration data in the now familiar way for
a two-source mark-recapture analysis. Their work was
thus the forerunner of the enormous number of appli-
cations in epidemiology which correct for incomplete
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ascertainment in lists with partial coverage (Hook and
Regal, 1995, International Working Group for Disease
Monitoring and Forecasting, 1995a, 1995b), as well
as the area of evaluating the actual coverage achieved
by censuses of (human) populations by means of post-
enumeration surveys (Fienberg, 1992). It includes the
idea of estimating within subpopulations, partly in or-
der to check the essential assumption of independence
between each source, and also as a means of reduc-
ing the potential impact of heterogeneity in “capture”
probabilities. In this respect it anticipates the applica-
tions that concern us in the present paper.
Our focus here is on one important practical applica-
tion: estimating the sizes of populations of drug users,
often within the confines of a single city, by appli-
cation of the mark-recapture methodology. The same
methods are applicable to other “hard-to-reach” pop-
ulations, usually with public health implications, such
as sex workers (McKeganey et al., 1992). These ap-
plications differ from correcting for incomplete ascer-
tainment in that it is unlikely that there exists any
list that has some pretension to approaching compre-
hensive coverage of a well-defined population. They
thus come closer in concept to the ecological applica-
tions in which a number of samples are drawn from
the population. In our context, these “samples” will be
sources of information such as lists of drug users who
attended treatment services or were arrested by the po-
lice within a certain interval of time. The natures of
these samples—and indeed of the population itself—
raise many issues which demand consideration.
1.2 The Influence of Richard Cormack
We are indebted to Richard Cormack for providing
support and advice during the early studies in Scot-
land, which directly followed the approach to applying
the method outlined in Cormack (1985, 1989, 1992).
In particular, he generously shared his suite of macros
in GLIM4 (Francis, Green and Payne, 1992) to repli-
cate the approach outlined in that paper. Another im-
portant paper that informed the earlier applications in
the drug use field was Fienberg (1972), along with the
more general information about log-linear models in
Bishop, Fienberg and Holland (1975). The support that
Richard Cormack gave was perhaps a double-edged
sword, as it enabled researchers to be able to quickly
generate mark-recapture estimates once a contingency
table, denoting presence and absence from different
data sources, had been constructed and translated into
the format used by GLIM4 or also SPSS, which was
the main statistical package used by nonspecialists to
carry out mark-recapture analyses. The downside was
that the mark-recapture method was now being used by
researchers who perhaps did not have sufficient statisti-
cal background to either apply anything more than the
most standard application of the method or, more wor-
ryingly, to understand or check whether they were ap-
plying the method correctly in the first place. While the
same can perhaps be said about any statistical method
that is used by nonstatisticians, this may be a more
prominent issue with the specialist or niche applica-
tion of the mark-recapture method to estimate drug use
prevalence.
The review of drug use applications of mark-
recapture methods includes several acknowledgements
of Cormack’s important contributions to a variety of
studies at the time when this area of application was
still under development.
2. PROBLEM DRUG USE
It is a basic tenet in statistical investigation that a
clear and unequivocal definition of the population of
interest is vital. Therefore, any study that aims to esti-
mate the prevalence of problem drug use needs to pro-
vide a description of the case definition employed for
identifying problem drug use. Measures of drug de-
pendence, such as the International Classification of
Diseases (ICD) codes or the Diagnostic and Statisti-
cal Manual of Disorders (DSM) diagnostic criteria, are
not commonly used in sources of data on drug use and
therefore would be of little use in this type of preva-
lence estimation exercise. Rather, the study considers
drug use measures that are readily available in data that
can systematically be collated across the country. As
such, the case definition of the prevalence estimates de-
pends heavily on the case definitions used by the con-
tributing sources. The European Monitoring Centre for
Drugs and Drug Addiction (EMCDDA) promotes the
use of mark-recapture to estimate “high risk drug use”
defined as “recurrent drug use that is causing actual
harms (negative consequences) to the person (includ-
ing dependence, but also other health, psychological or
social problems) or is placing the person at a high prob-
ability/risk of suffering such harms” (European Moni-
toring Centre for Drugs and Drug Addiction, 2013). It
is obvious that this is not a watertight, operational case
definition as would be expected in an epidemiologi-
cal study. In fact, “it can be considered a theoretical or
conceptual definition [which] implies appropriate flex-
ibility in reporting” and “the main point of these case
definitions is to filter out experimental and occasional
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users who have a lower risk of harms and are not the
core population for the assessment of treatment need”
(European Monitoring Centre for Drugs and Drug Ad-
diction, 2013). The difficulty of defining the population
carries over into the difficulty of knowing from which
population each sample has been drawn and whether,
in fact, they have all been drawn from the same pop-
ulation. In a typical application, the sources (samples)
could include lists of clients entering treatment for a
drug use problem and lists of people arrested for drug
use offences. Do these draw on the same population?
These are not issues that arise uniquely in relation to
using mark-recapture methods among drug users, but
they are always present in these applications. It could
be said that, in our area of application, the usual rela-
tionship between population and sample is turned on its
head. We do not have a well-defined population from
which we plan the sampling. Rather, we have sam-
ples that happen to be available—usually only three or
four—and the population is implied by the nature of
these samples. For example, in Greece, estimates have
been obtained annually since 2004 by exploiting the
fact that the national database of demands for treat-
ment for a drug problem is collected in three parts,
not by design but as a consequence of different ser-
vices’ concerns over data protection. Selecting only the
clients who declare that their main substance of abuse
is a drug such as heroin and treating the three parts
as separate sources enables mark-recapture estimation
of the population of high-risk drug users in Greece as
in Richardson and Antaraki (2015). Consequently, we
are estimating the size of a pool of self-reported opioid
abusers who are liable to seek treatment.
3. A STANDARD APPROACH
Along with recommending a common case defini-
tion such as high-risk drug use, the EMCDDA also rec-
ommends a standard approach to using mark-recapture
methods to estimate drug use prevalence, following
that used in early studies that benefited from Cor-
mack’s advice.
A standard set of Poisson log-linear models are fitted
to the overlap data recording the frequencies of patterns
of presence/absence in the various data sources (see ex-
ample in Table 1). Where there are three sources of data
on drug users (the typical minimum number of sources
for a mark-recapture study), these models are the fol-
lowing: the independence model (with no relationships
or interactions between data sources), then three differ-
ent models that each contain just one two-way interac-
tion, three further models that have two such interac-
tions and a “saturated” model that has three two-way
interactions. As there is one missing cell (the hidden
population we are seeking to estimate), it is not pos-
sible to estimate the three-way interaction. Comparing
the value of the deviance to the χ2 distribution could
suggest the “best” model and information criteria such
as the AIC value are also useful in assessing different
models and estimates. An example using four sources
is given in Section 4.1, whereas Table 1 gives an ex-
ample of Greek data from 2012 used in a three-source
TABLE 1
23 contingency tables (overlap tables) constructed from Greek data on presence/absence of drug
users in three treatment sources. “?” denotes the unobserved “hidden” population. The total
population is the total observed plus the estimated hidden population obtained from the
best-fitting model (S1 + S2 + S3 + S2.S3) in each age group
Source Age group (years)
S1 S2 S3 15–24 25–34 35–64
Yes Yes Yes 1 8 7
Yes Yes No 12 118 51
Yes No Yes 1 28 18
Yes No No 139 1149 1239
No Yes Yes 10 74 20
No Yes No 143 694 308
No No Yes 41 212 124
No No No ? ? ?
Total observed 347 2283 1767
Estimated total population 2273 9595 9136
95% confidence interval 1478–3893 8142–11,060 7546–11,288
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analysis. The model that includes the S2.S3 interac-
tion (in addition to all three main effects) is a good
fit in each age group. The confidence intervals in Ta-
ble 1 were obtained using the profile likelihood method
(Cormack, 1992, Regal and Hook, 1984).
Although models that include covariates such as age
group and gender are available, the typical approach in
many of the earlier studies to deal with heterogeneity
was to carry out separate analyses on stratified over-
lap tables, not least because separate estimates by age
(and by gender) are requested by agencies or organi-
zations such as the EMCDDA. In other circumstances,
separate estimates are obtained naturally for different
geographical areas. If these must be combined into a
total, a question arises of how to construct a confi-
dence interval around the point estimate. One solution
is to use bootstrapping methods, such as those used by
Gemmell, Millar and Hay (2004) when summing esti-
mates for ten areas of Greater Manchester.
A natural objection to the standard approach de-
scribed above is that it takes no account of model un-
certainty. Model averaging can be applied as in Hook
and Regal (1997), who suggest using weights pro-
portional to e−AIC/2. However, constructing model-
averaged confidence intervals is problematic in the fre-
quentist framework (Claeskens and Hjort, 2008). On
the other hand, model averaging emerges naturally
from a Bayesian analysis of the data (discussed later),
which can be carried out very easily using the R pro-
gram “conting” (Overstall and King, 2014).
There is debate as to whether fitting the saturated
model is appropriate, as, by default, it always fits the
data exactly. Because its fit cannot be assessed, it is
perhaps a leap of faith as to whether relying on the sat-
urated model gives a reliable estimate. In many of the
early three-sample studies it can be noted that the satu-
rated model gives a higher estimate of the hidden pop-
ulation than models with fewer interaction terms and
this issue also perhaps makes some people try to avoid
fitting the saturated model.
There are, of course, assumptions underlying the ap-
plication of mark-recapture methods to estimating the
size of animal or human populations. For our example
it is assumed that the population of drug users does not
change during the study. Specifically, it is assumed that
drug users do not begin to use drugs or stop using drugs
and that drug users do not move into or out of the area
that is being studied within that time period. Clearly,
these assumptions can hold only approximately at best.
The shorter the period, the more likely they are to be
to be valid, but the data—especially the overlaps on
which mark-recapture depends—may be sparse. The
standard period of one year may be a reasonable choice
but should be examined. Some published studies have
included sources with shorter time periods, often in or-
der to increase the number of sources. For example,
the same source of information in each trimester of
the year was counted as four mark-recapture sources in
Domingo-Salvany et al. (1995). The same device has
also been used over two-year study periods in order to
obtain first estimates in places where data sources are
limited (Choi and Comiskey, 2011, Kraus et al., 2011).
It is also assumed that drug users who are in more
than one data source are correctly identified as such. In
the drug use example, this assumption usually relates
to how accurately overlap cases can be identified when
comparing initials and dates of birth, particularly from
data sources where accuracy of recording may be less
than that seen in, for example, clinical settings.
Although we do not require sources to be statistically
independent (except of course in a two-source analy-
sis, which is not under discussion here) because their
dependence is handled by interaction terms in the log-
linear model, there is the possibility that the services
and agencies that provide the data operate in relation
to each other. Suppose that presence in one source pre-
cluded presence in another. This might be so if one
source was prison or if the sources were mutually ex-
clusive forms of treatment. Then clearly the overlap be-
tween the two should be a structural zero in the table
and a more complicated analysis is required (or, more
simply, the two forms of treatment could be combined
into one source). Another possible relationship is pres-
ence in one source implying presence in another, as, for
example, arrested drug users being sent automatically
to a treatment service, in which case the police source
would simply be a subset of the treatment source. It is
also assumed that the contributing data sources should
be representative. In order to meet this assumption,
data sources must have equal coverage of the area they
serve and also be representative of gender, age group,
ethnic group, type and severity of drug use, etc. That is
not to say that, for example, a treatment service should
have equal numbers of female and male clients, rather
the probability that a female drug user in the commu-
nity appears in a treatment data source is similar to that
of a male drug user (or that drug users in a rural part of
a county are as likely to access treatment as drug users
living in a town or city). This is an issue of homogene-
ity or heterogeneity which is often handled by breaking
the data down by gender, age and other groupings.
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4. REVIEW OF THE DRUG USE APPLICATIONS OF
MARK-RECAPTURE
In this section we review some of the earlier appli-
cations of the mark-recapture method in estimating the
prevalence of problem drug use. Our focus is on stud-
ies carried out within the United Kingdom (beginning
with Scotland where Richard Cormack is based and is
most influential) which largely followed the “standard
approach” described above. We consider the one-off
studies carried out in Scotland which led to a series of
regular national and local estimates being produced ev-
ery three years, and go on to describe how prevalence
estimation in England also developed from various lo-
cal studies into a more systematic application of the
method (and related methods) on an annual basis. We
first review some of the European work in this area.
4.1 European Studies
At the European level, the motivation for many of
the earlier drug prevalence estimation studies was to
provide information for organizations such as the then
newly established EMCDDA of the European Union
or the Pompidou Group of the wider Council of Eu-
rope. The EMCDDA jointly with the Pompidou Group
published a scientific monograph which included four
chapters covering the application of mark-recapture
methods to problem drug use prevalence estimates
(Domingo-Salvany, 1997, Richardson, 1997, Bello and
Chêne, 1997, Frischer, 1997). Both of the present au-
thors have been associated with the EMCDDA since
it was established in 1995, particularly through their
national centers responsible for providing information
on the issues of drug use in their countries. These Na-
tional Focal Points structure much of their reporting
to the EMCDDA around five Key Indicators, one of
which is the size of the population of problem drug
users or High-risk Drug Users. Mark-recapture is one
of the methods promoted in the guidelines for estima-
tion (European Monitoring Centre for Drugs and Drug
Addiction, 1999). Thus, many EU countries, plus Nor-
way and Turkey, are regularly producing estimates us-
ing this methodology.
Important early applications in Europe include stud-
ies in Barcelona, Spain (Domingo-Salvany et al.,
1995, 1998), and in Dublin, Ireland, where an estimate
initially attracted mixed responses (Comiskey, 2001,
Comiskey and Barry, 2001) but later seemed to be ac-
cepted (Kelly, Carvalho and Teljeur, 2003).
4.2 United Kingdom Studies
In the 1980s the threat to public health of the spread
of HIV/AIDS became apparent. While initial atten-
tion focused on men who have sex with men and
people who inject drugs, it was recognized that HIV
could spread via heterosexual sex and could impact on
groups other than the specific subgroups it had initially
been seen in. In 1985, when a test for HIV became
available, blood samples from patients attending an ac-
cident and emergency department who were known to
be injecting were tested and over 60% were found to be
positive (Robertson and Richardson, 2007). This high-
lighted a public health threat, but without information
on the number of drug injectors in Edinburgh, little was
known about the total number of people infected with
the virus.
As part of the team working within the Glasgow
site of a World Health Organization multi-city study
on HIV and drug injecting (Des Jarlais, 1994), Mar-
tin Frisher became one of the first researchers in Eu-
rope to use the mark-recapture method in a drug-
using population, specifically to estimate the number of
drug injectors in Glasgow (Frischer et al., 1991, 1993,
Frischer, 1992a). Although the title of one of the papers
suggested that mark-recapture was a new method in
this context, which perhaps overlooked Hartnoll et al.
(1985) and Doscher and Woodward (1983), it does ex-
pand on the epidemiological grounding of the method.
That study can now be considered as groundbreaking,
particularly because it was the first to use four data
sources and it demonstrated that a successful study
could use existing administrative data sources or data
that were being collected for other purposes (such as
estimating HIV prevalence) and, unlike Hartnoll previ-
ously, did not require a lot of additional data collection.
It should be noted that Frischer et al. (1993) includes
Richard Cormack as an author, as does a later paper by
another group that provided estimates for Edinburgh
(Davies, Cormack and Richardson, 1999).
While pioneering the application of mark-recapture
methods to estimating the prevalence of problem drug
use, Frisher was also required to defend the method
(Frischer and Leyland, 1992) and respond to criticism
(Frischer, 1992b), such as that in the commentary piece
by Armstrong and Hayes (1992).
Later on in Scotland, a study set out to build upon
the work of Frisher by applying the method in Dundee
(Hay and McKeganey, 1996, Hay, 1997). Richard Cor-
mack, although not credited as an author of the paper,
provided support and advice to the project team, par-
ticularly by allowing free access to his GLIM4 macros
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(Cormack, 1985). The case definition of opiate and/or
benzodiazepine use was applied in an attempt to recog-
nize the “hard drug use” situation in that city at a time
when a “heroin drought” had led to people using (in-
cluding by injection) benzodiazepines. Although that
case definition was employed for a specific situation, it
has stuck for all subsequent drug use prevalence esti-
mation studies in Scotland, leading sometimes to dif-
ficulty in making comparisons to opiate use estimates
elsewhere in the UK or Europe. A similar study was
carried out in urban and rural areas of the northeast of
Scotland (Hay, 2000).
These local studies developed into a series of na-
tional prevalence estimation exercises on a three-yearly
basis that used a common methodological approach
stretching from 2000 to 2012 where trends can be ex-
amined (Hay and Gannon, 2006, Hay et al., 2009a,
Information Services Division, 2014).
An important point in the historical development of
mark-recapture estimation of the size of drug-using
populations in the United Kingdom was Hartnoll et al.
(1987), who collated information on drug users in an
area of London. That study could be seen as aris-
ing from a local initiative which tried to quantita-
tively assess drug use in a particular area, includ-
ing applying prevalence estimation methods such as
multiplier methods or the two-sample mark-recapture
method. While aware of the benefits of using more than
two sources of data within a mark-recapture method,
the published analyses in Hartnoll et al. (1985) were
restricted to the two-sample mark-recapture method.
Hartnoll’s work could, in part, be seen as responding
to the increasing public health concerns about drug use
when levels of heroin use in some areas such as Lon-
don were rising after staying relatively stable since the
introduction of the Misuse of Drugs Act in 1971.
Other local estimates in the United Kingdom pro-
duced in the 1990s include Squires et al. (1995) who
produced an estimate for Liverpool, Beynon et al.
(2001) who compared and contrasted estimates across
the North West of England (an area that experienced
relatively high levels of opiate use in the early 1980s)
and Brugha et al. (1998) who applied the method in
a more rural area. Elsewhere in the United Kingdom,
studies estimated the prevalence of drug use in North-
ern Ireland (McElrath, 2002, Hay et al., 2006) and in
Wales (Bloor, Wood and Palmer, 2000).
In 2002 the UK Government commissioned three
methodological pilot studies in England to estimate
drug use prevalence. One used mark-recapture meth-
ods in Greater Manchester, updating previous esti-
mates of the prevalence of opiate use (Beynon et al.,
2001). Another used mark-recapture methods to es-
timate the prevalence of opiate use in Liverpool,
Brighton and parts of Inner London (Hickman et al.,
1999), and a third project used the multivariate indi-
cator method (MIM) to estimate the number of opi-
ate users in England (Frisher, Heatlie and Hickman,
2007). MIM, which was considered by the EMCDDA
to be appropriate for estimating the prevalence of opi-
ate use at the national level (Kraus et al., 2003), is
essentially a multiple linear regression model which
places available prevalence estimates (derived using
the mark-recapture method) in a regression model with
available “indicator” data such as numbers of opiate
users in treatment or other indicators that are thought
to be correlated with opiate use.
Following on from these pilot studies, the UK Home
Office commissioned a series of annual estimates of
the prevalence of opiate use in England, along with
estimates of the number of people who use crack co-
caine or the number of people who use either opiates
or crack (Hay et al., 2009b, 2010, 2011). The inten-
tion was to provide mark-recapture estimates for each
of the 149 local areas of England, which is the level
at which the planning and provision of drug treatment
services and other responses to drug use is decided,
and at which information on prevalence is particularly
needed. While the decision to stratify the analyses at
the local area level was more about providing local
estimates, it also helped to address the heterogeneity
that would be present at the regional or national level.
Where the mark-recapture method failed to provide
what was subjectively considered to be a valid esti-
mate, then MIM would be used to fill in the gaps.
The four data sources on problem drug use which
could be used within these mark-recapture analyses
were treatment, police, prison and probation data and
these were all held centrally at the national level. The
available data allowed analyses at the local (n = 149),
regional (n = 9) and national level. Age group and
gender could be used to stratify the data. As a key
objective of the study was to obtain comparable esti-
mates in order to assess differences between areas and
changes over time, a standard analysis plan was devel-
oped (Hay et al., 2010). Essentially it restricts model
fitting to a set of 22 simple models and seeks the “best
estimate” for a particular area by considering differ-
ent combinations of estimates stratified by age group
and/or gender. The 22 simple models were the inde-
pendence model, six models with only one two-way
interaction and the fifteen models that include a pair
of two-way interactions. Various methods were used
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to explore whether the model fitted to the unstratified
data was a good fit (in particular by considering the
AIC value). If none of those approaches provided what
was thought to be a valid estimate, then MIM was used
instead. Estimates for specific age groups were ob-
tained in a similar manner to that outlined in Hay et al.
(2009b), which involved deriving an estimate for the
proportion in each age group from the best available in-
formation (typically mark-recapture estimates that em-
ployed model-averaging over the simplest 22 models)
and applying those proportions to the “best” available
estimate which could be a MIM estimate. Confidence
intervals for the regional and national estimates were
obtained using the approach outlined in Gemmell, Mil-
lar and Hay (2004). This led to extreme asymmetry in
the confidence intervals for the age group estimates,
most likely due to the large number of confidence in-
tervals that had been approximated by simulated dis-
tributions. Table 2 gives an example of the data for an
area of London.
Across the years of the English studies, the national
estimates stratified by age group suggest that the num-
ber of opiate users aged 15 to 24 decreased over time,
as did those in the 25 to 34 age range (Table 3). Analy-
ses based on simulation methods confirmed these sig-
nificant differences. Interestingly, the estimates in the
older age group increased over time. As the increase
each year is similar to the number of opiate users who
would turn 35 and therefore move into the older age
range, the increases could perhaps be explained as be-
ing due to an ageing cohort.
A consistent finding across the successive years of
the English studies is that estimates at lower area lev-
els have relatively wide confidence intervals which do
not allow significant changes to be identified across
time, but adding estimates to get regional or national
estimates reveals more consistent trend information.
The level of geographical stratification is important.
Stratifying to the lowest level possible maximizes the
information provided, although the resulting compar-
atively large confidence intervals may render over-
stratified estimates worthless. Also, when summing lo-
cal estimates to get regional or national estimates, it
may be beneficial to keep the number of stratified esti-
mates low in order that the larger area estimates do not
have over-large confidence intervals. Questions should,
however, be asked about the comparability of estimates
when some of the mark-recapture analyses are for rel-
atively large geographical areas covering an urban and
rural mix and some for relatively small urban areas.
There may have been merit in stratifying large ar-
eas into geographical subareas to see if geographical
heterogeneity was present. There did appear to be an
issue in the analyses that the simplest 22 models (as
described above) were less likely to provide an ade-
quate fit in the larger geographical areas and consis-
tently throughout the repeated years of the study there
were areas where all of the deviance values for the
TABLE 2
A typical overlap pattern found in an area of London, Year 1 to Year 8; by age group in Year 8
Source Year 1 Year 2 Year 3 Year 5 Year 6 Year 7 Year 8
S1 S2 S3 S4 15–64 15–64 15–64 15–64 15–64 15–64 15–24 25–34 35–64
Yes Yes Yes Yes 0 0 0 2 2 1 0 0 0
Yes Yes Yes No 0 0 1 1 0 0 0 0 0
Yes Yes No Yes 1 3 3 7 5 2 1 0 0
Yes Yes No No 2 5 4 19 8 2 0 0 0
Yes No Yes Yes 0 0 0 0 0 1 0 0 0
Yes No Yes No 0 1 1 0 2 0 0 0 0
Yes No No Yes 0 2 1 1 1 0 0 0 0
Yes No No No 4 10 11 12 17 22 8 10 1
No Yes Yes Yes 3 3 16 15 10 15 1 4 3
No Yes Yes No 9 6 11 30 22 19 0 7 9
No Yes No Yes 10 14 29 26 33 37 2 10 21
No Yes No No 280 342 339 342 348 361 25 128 208
No No Yes Yes 3 0 1 5 4 3 0 0 4
No No Yes No 11 13 16 28 31 25 5 12 6
No No No Yes 4 17 14 27 32 32 1 9 6
No No No No ? ? ? ? ? ? ? ? ?
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TABLE 3
Table summarizing prevalence estimates by age group in England
Age 15–24 Age 25–34 Age 35–64
Year Estimate 95% CI Estimate 95% CI Estimate 95% CI
1 59,583 n.a. 124,004 n.a. 97,740 n.a.
2 51,099 (50,311–54,569) 129,128 (125,614–134,005) 106,264 (104,113–111,433)
3 44,398 (43,296–47,493) 118,385 (115,969–123,126) 110,340 (107,905–114,727)
5 36,546 (35,193–39,879) 109,509 (106,991–111,604) 116,374 (113,981–118,513)
6 35,740 (34,204–37,449) 105,770 (103,035–108,132) 122,563 (119,442–125,031)
7 30,278 (28,819–31,980) 100,887 (98,739–103,213) 130,628 (127,847–133,506)
8 24,942 (23,475–26,488) 95,950 (93,352–97,923) 135,271 (131,740–137,843)
simplest 22 models were far in excess of that found
in other areas, perhaps indicating that there could be
some breach of the mark-recapture assumptions. There
is also the issue that, just because it is possible to get
models to fit the data, it does not necessarily mean that
the assumptions hold and that the estimates are reli-
able.
5. METHODOLOGICAL ADVANCES
In this section we examine how the “standard ap-
proach” has been further developed in two respects
to try to address some of the particular methodologi-
cal issues in using mark-recapture to estimate drug use
prevalence.
5.1 Bayesian Approach
Naturally, the Bayesian approach to log-linear mod-
eling of mark-recapture data on drug users has been
considered. The best examples can be found in a se-
ries of papers concerning the estimation of the num-
ber of people who inject drugs in Scotland in different
years (King et al., 2005, 2009, 2013) and subsequently
in England (King et al., 2014). In marked contrast to
the innumerable applications of Bayesian methodology
throughout the statistical literature in which only unin-
formative prior distributions are employed, these pa-
pers set out in detail their priors based on expert opin-
ion and results obtained elsewhere.
The advantages of the Bayesian approach include the
natural way of averaging across models by weighting
according to the posterior probabilities of models that
have been examined in the Markov chain Monte Carlo
procedure. Similarly, inclusion of a specific interaction
can be judged on the basis of a probability rather than
as the yes–no decision taken in the usual frequentist
model selection. Of course, all this takes place within
a specific set of models. The Scottish data form a 27
contingency table constructed from four sources and
three two-level covariates (age, gender, region) with
one missing cell for each combination of the covari-
ate values. In order to keep the number of models
to manageable proportions, nonzero prior probabilities
were assigned only to the two-way interactions. Con-
sequently, models containing three-way and higher or-
der interactions were excluded. This might be reason-
able as far as the sources are concerned, but possibly
requires examination for interactions that also include
covariates.
An interesting feature of the posterior probability
densities of total population size in some analyses was
the appearance of bimodality. This can be seen most
clearly in the Scottish data for 2003 presented in Fig-
ure 1 of King et al. (2009) with a low peak at about
22,000 and a higher one around 30,000. The greater
posterior probability attached to the model that pro-
duced the latter estimate resulted in a final estimate
of 27,357. The difference between the two peaks was
traced chiefly to whether or not the interaction between
sources S3 and S4 was included. As the coefficient
of the corresponding term in the log-linear model had
positive posterior mean, its exclusion would tend to re-
duce the estimated population sizes. This interaction
had a lower posterior probability (0.84) for inclusion
than the other terms that appeared to be required, in-
dicating some support for its exclusion and hence the
presence of the lower peak. The fuller model contain-
ing S3.S4 might not have been identified within the
conventional frequentist approach. There are too many
possible models to search through all in order to find
the “best” (for example, by smallest value of AIC).
However, starting as did King et al. (2009) by exclud-
ing three-way and higher order interactions from con-
sideration, the usual process of eliminating and rein-
serting terms as necessary does lead in the end to their
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model that contains 12 two-way interactions includ-
ing S3.S4. Alternatively, if one were to start from the
model that includes all 3-way interactions, then the
need for S1.Age.Gender and S4.Age.Gender would be
indicated. Neither seems a priori unreasonable. Elim-
inating superfluous two-way interactions results in a
model with good fit (deviance 113.1 on 96 d.f., p =
0.11; AIC 583.4 compared to 582.4 from the model
with the 12 2-way interactions). Lacking the S3.S4 in-
teraction, however, it gives a relatively low estimate of
population size. This example indicates the difficulty
of selecting a final model for a large table. However,
one factor that may have played a role could be that the
table is relatively sparse, with 24 sampling zeros in its
120 cells; only 46 of the 7201 observations represent
people who were observed in three sources and only
one person appeared in all four.
5.2 Open Populations
The typical mark-recapture analysis for estimating
the size of a population of drug users is based on
a small number of contemporaneous samples (often
only three), using anonymized identification codes in
order to match people between samples and estimat-
ing the size of the closed population over a short pe-
riod of time. This automatically excludes drawing upon
the vast literature on mark-recapture analysis in other
fields, which is largely based on successive sampling,
possibly over a long period, a structure that enables—
and in fact demands—the consideration of open pop-
ulations. However, if the mark-recapture data on drug
users are collected each year, this raises the possibil-
ity of studying an open population by matching across
years to construct a capture history as in an ecological
application. This will not always be feasible for practi-
cal reasons. Even with routine administrative sources,
coding the identifiers is sometimes only carried out
upon special request for the particular purpose of per-
forming one-off mark-recapture estimation. In other
cases, because of anxiety over data confidentiality, the
codes are used solely for matching within the year and
then deleted, so that they are not available for further
use. However, if an agency holds its own data and con-
structs the codes as a matter of course, an open popu-
lation analysis over years could be carried out in prin-
ciple, based on the seminal work of Jolly (1965) and
Seber (1965). Among other things, this could show
the incidence of starting drug use, complementing the
prevalence indicated by the existing annual estimates.
There have been some studies that include an open-
population mark-recapture analysis. In comparing dif-
ferent approaches to estimating the size of a drug-using
population in Sydney, Australia, Kimber et al. (2008)
use a parameterization of the Jolly–Seber model due
to Schwarz and Arnason (1996). More recently, us-
ing the same parameterization, Van Dam-Bates, Fyfe
and Cowen (2016) published an analysis of just three
years’ data for the city of Victoria, Canada. Other pro-
posals for using the Jolly–Seber model date back to a
special journal edition of the Journal of Drug Issues
where Hser (1993) and Brecht and Wickens (1993)
consider the same application of the method to data for
Los Angeles County (with the latter also using sim-
ulated data to compare methods). Both articles con-
cluded that the Jolly–Seber model underestimated the
true population size. A more extensive analysis is cur-
rently in progress of 13 years of Greek data, using
records from only one of the three treatment sources
mentioned above as being employed in the annual es-
timation procedure (codes from the other two sources
are not retained because of confidentiality concerns).
Although the first results appear to need considerable
refinement, especially because of poor fit to individ-
uals who appear repeatedly, they show a high degree
of consistency with the annual three-source estimates,
which may not be surprising given the use of the same
data in both analyses. Unfortunately, the annual inci-
dence (“birth” in the usual terminology of open popu-
lation analysis) is rather poorly estimated with typical
values around 3000–4000 and standard errors of about
700.
One possibly important advantage of the open pop-
ulation analysis is that it only requires a single source;
consequently, it can be applied when the minimum re-
quirement of three sources for the closed-population
mark-recapture analysis is not met. Of course, as is
well known, population size for the latest year cannot
be estimated except by imposing equal capture prob-
abilities across years, which may be undesirable. As
an aside, we mention here that another well-known
method for estimating annual population sizes from
repeated captures in a single source is sometimes ap-
plied to drug users. This is the analysis based on the
truncated Poisson distribution for the number of cap-
tures using, for example, Zelterman’s estimator; see
Böhning and Van der Heijden (2009). This method
has been used in a number of settings, such as esti-
mating the number of drug users in Bangkok, Thai-
land (Böhning et al., 2004), and estimating the num-
ber of injectors in Aberdeen using data from a needle
exchange (Hay and Smit, 2003).
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6. DISCUSSION
We have demonstrated that the mark-recapture
method can be used to estimate the prevalence of prob-
lem drug use both at the local level and, usually in con-
junction with other statistical methods, at the national
level. Thus, Scotland and England have acquired series
of prevalence estimates following the same approach
(originally based on the advice and support of Richard
Cormack) applied systematically across time. These
studies have identified that the prevalence of problem
drug use in Scotland has remained relatively constant,
whereas in England it appears to be decreasing, partic-
ularly among younger people. Across Europe various
local estimates, again obtained using mark-recapture,
are informing the work of the EMCDDA.
It has, however, become increasingly difficult to
carry out a mark-recapture study, not because of the
methods (or even changes in the nature of the data),
but due to increased concerns about sharing the type of
personal data (such as initials and dates of birth) re-
quired to identify overlaps. Even in countries where
all citizens have unique identification codes—for ex-
ample, Denmark where mark-recapture has been used
to estimate the prevalence of hepatitis (Christensen
et al., 2012, Hansen et al., 2014)—issues relating to
data protection legislation and client or patient con-
fidentiality are becoming more and more prominent.
While it is possible to construct unique numeric codes
to anonymize or “pseudonymize” personal data, since
these are based on personal data, the data protec-
tion concerns still remain (along with all the attendant
data security issues such as safe storage and transfer).
A perfect way of anonymizing the personal data for
matching should not detract from the ability to carry
out a mark-recapture study, but often this can introduce
an added layer of complexity into the analysis or pre-
vent identification of problems with the data.
Data providers such as the police or treatment ser-
vices usually consider the data they are asked to pro-
vide as personal and confidential and often seek to re-
strict use to the purpose for which it was requested.
While it can be argued that the overlap data are suffi-
ciently removed from personal data (particularly when
cell values are large enough to prevent deductive dis-
closure), data providers sometimes place restrictions
on the dissemination and publication of such data. The
peer-review process of Hay et al. (2009b) requested
that the original overlap patterns be supplied in an ap-
pendix, however, permission to do this was not forth-
coming from the contributors of data and even the pub-
lished information about which models were fitted to
the overlap data was not for named areas. Although for
a statistician it would be good practice to share source
data, it has not always been possible with the data
collected during the various United Kingdom mark-
recapture studies, the notable exception being the stud-
ies that applied Bayesian mark-recapture methods to
the same data in England and Scotland; this involved
the original study team preparing overlap patterns in
the required format (such as aggregating up to regional
level).
There has been criticism of the “standard approach”
used within the United Kingdom studies. In part, this
criticism is justified, as the behaviors of human pop-
ulations and their involvement with criminal justice
services and drug treatment agencies are complex and
it would be over-optimistic to believe that the mark-
recapture assumptions are fully valid. Since the in-
crease in the use of the method to estimate the size of
drug-using populations in the 1980s and 1990s, there
has been criticism such as Waters (1994) who felt
more validation of the method was required in response
to LaPorte (1994) who suggested that mark-recapture
could bring about a “paradigm shift in how counting
is done in all the disciplines that assess human popula-
tions”.
The validity of the English estimates was also ques-
tioned by Frisher and Forsyth (2009) who pointed out
that an increase in prevalence between 2001 and 2004
was not matched by other available data, such as the
number of drug-related deaths or the number of hospi-
tal admissions due to drug abuse.
More recently, Jones et al. (2014) suggest that stan-
dard mark-recapture methods may be fallible when
used to estimate the size of covert human populations,
particularly in the presence of referrals between data
sources such as when the police or a prison refer peo-
ple into drug treatment. They suggest that this issue
is not quite the same as the main assumptions that are
routinely considered when using mark-recapture. Their
approach to trying to demonstrate this proposed falli-
bility is based on highlighting differences between the
results of their analyses and the estimates that had been
previously published using the same data in Hay et al.
(2011), which carried out the analyses at the local area
level and often stratified by age group or gender (as
well as area of residence), as it was thought unlikely
that all drug users across England demonstrated equal
“capture probability”. Jones et al. (2014) did not con-
sider geographical, age or gender heterogeneity, as they
carry out their analyses only with data aggregated up
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to the national level. Their simulated datasets are simi-
larly only analyzed at the national level.
The use of a second method in some areas was not
noted in the comparisons. This is an important omis-
sion, as MIM was used in the English analyses when
the mark-recapture method failed to provide a valid es-
timate when fitting the 22 simplest models. This could
be because these models do not fit the data due to
remaining heterogeneity, dependencies between data
sources or, indeed, the referral issue they are propos-
ing. It could also be due to data quality issues at the
local level, something that is not unknown when ana-
lyzing data on covert populations such as drug users.
It is often seen that fitting more complicated models
increases the estimated population size, which could
be a true reflection of prevalence or an inappropriate
attempt at dealing with unreliable data. Fitting over-
complicated models at the national level could there-
fore be one of many reasons why the comparisons they
make may not be valid. The same can be said about the
Bayesian analyses that always fit mark-recapture mod-
els, albeit at the regional level, even when it has been
difficult to fit models at the lower area level.
Finally, the criticism of the “standard approach”
is based on various three-sample analyses, some of
which involve fitting less commonly used nonhierar-
chical log-linear models. They cite Richard Cormack’s
description of fitting a three-way interaction when
only three sources are available as an “act of faith”
(Cormack, 1999). In the three-source scenario it usu-
ally is indeed an act or leap of faith, which is one of
the reasons why the English series of annual analyses
avoided using only three sources. However, when us-
ing four sources, fitting a four-way interaction is less
of a leap of faith when the available data suggest that
the leap from two-way to three-way interactions is not
required.
We have presented in some detail the use of mark-
recapture methodology to estimate the sizes of popu-
lations of drug users. This is possibly the most com-
mon application of the method in the social sciences.
Much of this work is carried out at a relatively unso-
phisticated level by the standards of modern statisti-
cal modeling, a situation which could and should be
improved. However, it is our impression that there is
a general feeling that the quality of the data that are
available in these applications is not adequate to sup-
port more than basic analyses. Mark-recapture samples
often comprise what already exists or can be extracted
from overworked and understaffed services, rather than
what would be employed in an ideal world. Practical
problems often dominate. Some of these may be the
same in nature, although not necessarily in degree, as
in other areas of application. For example, imperfect
matching across samples may occur in other epidemi-
ological analyses or in ecological studies, but may be
more prominent when the use of anonymized identifi-
cation codes is a necessity and some of the matching
information is provided by people who may have low
trust in services and could be under the influence of
drugs.
The major difficulty of case definition has been men-
tioned earlier, as well as the difficulty of ensuring that
the sources employ the same definition and thus can
be regarded as drawn from the same population. Often,
this will not be true. Police records and interviews with
trained psychologists in a treatment service are un-
likely to agree on the details of an individual’s status as
a drug user (substances used, injecting behavior). The
hope is that they agree sufficiently, although assess-
ing the validity of this pious hope is difficult and per-
haps rarely undertaken. It is worth mentioning, though,
some methodological innovations that address the is-
sue of incomplete agreement between sources. Van der
Heijden, Zwane and Hessen (2009) treat the problem
of lists that refer to nonidentical (though overlapping)
regions, time periods and age or other groups by ap-
plying the EM algorithm to the analysis of the incom-
plete tables formed from these lists. The same authors,
and also Zwane and van der Heijden (2007, 2008),
consider the similar issue raised by nonidentical sets
of covariates associated with each source. Overstall
et al. (2014), continuing their analyses of Scottish data,
presented a method of allowing for a broader defini-
tion in one of the four sources than in the other three.
Specifically, the hepatitis C virus diagnosis database
did not distinguish past from current drug injectors,
which made its use in the estimation of the number
of people who currently inject drugs problematic. This
broader definition implies that the contingency table
cell counts referring to people who were present only
in that database and not the others are left-censored. An
extension of previous models to include this feature al-
lowed this source’s inclusion in the modeling.
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